Búsqueda | Portal de Búsqueda de la BVS Enfermería

1.

Long-term outcomes in patients with relapsed or refractory hairy cell leukemia treated with vemurafenib monotherapy.

Handa, Shivani; Lee, Jeong-Ok; Derkach, Andriy; Stone, Richard M; Saven, Alan; Altman, Jessica K; Grever, Michael R; Rai, Kanti R; Shukla, Madhulika; Vemuri, Shreya; Montoya, Skye; Taylor, Justin; Abdel-Wahab, Omar; Tallman, Martin S; Park, Jae H.

Blood ; 140(25): 2663-2671, 2022 12 22.

Artículo en Inglés | MEDLINE | ID: mdl-35930750

2.

The impact of increasing karyotypic complexity and evolution on survival in patients with CLL treated with ibrutinib.

Kittai, Adam S; Miller, Cecelia; Goldstein, Daniel; Huang, Ying; Abruzzo, Lynne V; Beckwith, Kyle; Bhat, Seema A; Bond, David A; Grever, Michael R; Heerema, Nyla A; Rogers, Kerry A; Ruppert, Amy S; Byrd, John C; Woyach, Jennifer A.

Blood ; 138(23): 2372-2382, 2021 12 09.

Artículo en Inglés | MEDLINE | ID: mdl-34314481

3.

Phase 2 study of ibrutinib in classic and variant hairy cell leukemia.

Rogers, Kerry A; Andritsos, Leslie A; Wei, Lai; McLaughlin, Eric M; Ruppert, Amy S; Anghelina, Mirela; Blachly, James S; Call, Timothy; Chihara, Dai; Dauki, Anees; Guo, Ling; Ivy, S Percy; James, Lacey R; Jones, Daniel; Kreitman, Robert J; Lozanski, Gerard; Lucas, David M; Ngankeu, Apollinaire; Phelps, Mitch; Ravandi, Farhad; Schiffer, Charles A; Carson, William E; Jones, Jeffrey A; Grever, Michael R.

Blood ; 137(25): 3473-3483, 2021 06 24.

Artículo en Inglés | MEDLINE | ID: mdl-33754642

4.

Patient characteristics that predict Richter's transformation in patients with chronic lymphocytic leukemia treated with ibrutinib.

Kittai, Adam S; Huang, Ying; Beckwith, Kyle A; Bhat, Seema A; Bond, David A; Byrd, John C; Goldstein, Daniel; Grever, Michael R; Miller, Cecelia; Rogers, Kerry A; Yano, Max; Woyach, Jennifer A.

Am J Hematol ; 98(1): 56-65, 2023 01.

Artículo en Inglés | MEDLINE | ID: mdl-36216791

5.

Prognostic significance of translocations in the presence of mutated IGHV and of cytogenetic complexity at diagnosis of chronic lymphocytic leukemia.

Heerema, Nyla A; Muthusamy, Natarajan; Zhao, Qiuhong; Ruppert, Amy S; Breidenbach, Heather; Andritsos, Leslie A; Grever, Michael R; Maddocks, Kami J; Woyach, Jennifer; Awan, Farrukh; Long, Meixiao; Gordon, Amber; Coombes, Caitlin; Byrd, John C.

Haematologica ; 106(6): 1608-1615, 2021 06 01.

Artículo en Inglés | MEDLINE | ID: mdl-32414849

6.

Phase I Study of Veliparib on an Intermittent and Continuous Schedule in Combination with Carboplatin in Metastatic Breast Cancer: A Safety and [18F]-Fluorothymidine Positron Emission Tomography Biomarker Study.

Wesolowski, Robert; Stover, Daniel G; Lustberg, Maryam B; Shoben, Abigail; Zhao, Meng; Mrozek, Ewa; Layman, Rachel M; Macrae, Erin; Duan, Wenrui; Zhang, Jun; Hall, Nathan; Wright, Chadwick L; Gillespie, Susan; Berger, Michael; Chalmers, Jeffrey J; Carey, Alahdra; Balasubramanian, Priya; Miller, Brandon L; Amaya, Peter; Andreopoulou, Eleni; Sparano, Joseph; Shapiro, Charles L; Villalona-Calero, Miguel Angel; Geyer, Susan; Chen, Alice; Grever, Michael R; Knopp, Michael V; Ramaswamy, Bhuvaneswari.

Oncologist ; 25(8): e1158-e1169, 2020 08.

Artículo en Inglés | MEDLINE | ID: mdl-32452601

7.

Two-inhibitor salvage therapy for hairy cell leukemia.

Grever, Michael R.

Blood ; 141(9): 965-966, 2023 03 02.

Artículo en Inglés | MEDLINE | ID: mdl-36862436

8.

A phase I study of lenalidomide plus chemotherapy with idarubicin and cytarabine in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome.

Saygin, Caner; Larkin, Karilyn; Blachly, James S; Orwick, Shelley; Ngankeu, Apollinaire; Gregory, Charles T; Phelps, Mitch A; Mani, Shylaja; Walker, Alison; Garzon, Ramiro; Vasu, Sumithira; Walsh, Katherine J; Bhatnagar, Bhavana; Klisovic, Rebecca B; Grever, Michael R; Marcucci, Guido; Byrd, John C; Blum, William; Mims, Alice S.

Am J Hematol ; 95(12): 1457-1465, 2020 12.

Artículo en Inglés | MEDLINE | ID: mdl-32777116

9.

Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia.

Grever, Michael R; Abdel-Wahab, Omar; Andritsos, Leslie A; Banerji, Versha; Barrientos, Jacqueline; Blachly, James S; Call, Timothy G; Catovsky, Daniel; Dearden, Claire; Demeter, Judit; Else, Monica; Forconi, Francesco; Gozzetti, Alessandro; Ho, Anthony D; Johnston, James B; Jones, Jeffrey; Juliusson, Gunnar; Kraut, Eric; Kreitman, Robert J; Larratt, Loree; Lauria, Francesco; Lozanski, Gerard; Montserrat, Emili; Parikh, Sameer A; Park, Jae H; Polliack, Aaron; Quest, Graeme R; Rai, Kanti R; Ravandi, Farhad; Robak, Tadeusz; Saven, Alan; Seymour, John F; Tadmor, Tamar; Tallman, Martin S; Tam, Constantine; Tiacci, Enrico; Troussard, Xavier; Zent, Clive S; Zenz, Thorsten; Zinzani, Pier Luigi; Falini, Brunangelo.

Blood ; 129(5): 553-560, 2017 02 02.

Artículo en Inglés | MEDLINE | ID: mdl-27903528

10.

Population pharmacokinetics of lenalidomide in patients with B-cell malignancies.

Hughes, Jim H; Phelps, Mitch A; Upton, Richard N; Reuter, Stephanie E; Gao, Yue; Byrd, John C; Grever, Michael R; Hofmeister, Craig C; Marcucci, Guido; Blum, William; Blum, Kristie A; Foster, David J R.

Br J Clin Pharmacol ; 85(5): 924-934, 2019 05.

Artículo en Inglés | MEDLINE | ID: mdl-30672004

11.

Targeting Mutant BRAF in Relapsed or Refractory Hairy-Cell Leukemia.

Tiacci, Enrico; Park, Jae H; De Carolis, Luca; Chung, Stephen S; Broccoli, Alessandro; Scott, Sasinya; Zaja, Francesco; Devlin, Sean; Pulsoni, Alessandro; Chung, Young R; Cimminiello, Michele; Kim, Eunhee; Rossi, Davide; Stone, Richard M; Motta, Giovanna; Saven, Alan; Varettoni, Marzia; Altman, Jessica K; Anastasia, Antonella; Grever, Michael R; Ambrosetti, Achille; Rai, Kanti R; Fraticelli, Vincenzo; Lacouture, Mario E; Carella, Angelo M; Levine, Ross L; Leoni, Pietro; Rambaldi, Alessandro; Falzetti, Franca; Ascani, Stefano; Capponi, Monia; Martelli, Maria P; Park, Christopher Y; Pileri, Stefano A; Rosen, Neal; Foà, Robin; Berger, Michael F; Zinzani, Pier L; Abdel-Wahab, Omar; Falini, Brunangelo; Tallman, Martin S.

N Engl J Med ; 373(18): 1733-47, 2015 Oct 29.

Artículo en Inglés | MEDLINE | ID: mdl-26352686

12.

A novel regimen for relapsed/refractory adult acute myeloid leukemia using a KMT2A partial tandem duplication targeted therapy: results of phase 1 study NCI 8485.

Mims, Alice S; Mishra, Anjali; Orwick, Shelley; Blachly, James; Klisovic, Rebecca B; Garzon, Ramiro; Walker, Alison R; Devine, Steven M; Walsh, Katherine J; Vasu, Sumithira; Whitman, Susan; Marcucci, Guido; Jones, Daniel; Heerema, Nyla A; Lozanski, Gerard; Caligiuri, Michael A; Bloomfield, Clara D; Byrd, John C; Piekarz, Richard; Grever, Michael R; Blum, William.

Haematologica ; 103(6): 982-987, 2018 06.

Artículo en Inglés | MEDLINE | ID: mdl-29567781

13.

Biomedical Science Undergraduate Major: A New Pathway to Advance Research and the Health Professions.

Gunn, John S; Ledford, Cynthia H; Mousetes, Steven J; Grever, Michael R.

Teach Learn Med ; 30(2): 184-192, 2018.

Artículo en Inglés | MEDLINE | ID: mdl-29190142

14.

Safety and activity of BTK inhibitor ibrutinib combined with ofatumumab in chronic lymphocytic leukemia: a phase 1b/2 study.

Jaglowski, Samantha M; Jones, Jeffrey A; Nagar, Veena; Flynn, Joseph M; Andritsos, Leslie A; Maddocks, Kami J; Woyach, Jennifer A; Blum, Kristie A; Grever, Michael R; Smucker, Kelly; Ruppert, Amy S; Heerema, Nyla A; Lozanski, Gerard; Stefanos, Mona; Munneke, Brian; West, Jamie-Sue; Neuenburg, Jutta K; James, Danelle F; Hall, Nathan; Johnson, Amy J; Byrd, John C.

Blood ; 126(7): 842-50, 2015 Aug 13.

Artículo en Inglés | MEDLINE | ID: mdl-26116658

15.

The revised guidelines for the diagnosis and management of hairy cell leukaemia and the hairy cell leukaemia variant.

Troussard, Xavier; Grever, Michael R.

Br J Haematol ; 193(1): 11-14, 2021 04.

Artículo en Inglés | MEDLINE | ID: mdl-33368172

16.

Case 28-2018: A Man with Epistaxis, Pain and Erythema of the Forearm, and Pancytopenia.

Rogers, Kerry A; Blachly, James S; Grever, Michael R.

N Engl J Med ; 379(24): 2381-2382, 2018 12 13.

Artículo en Inglés | MEDLINE | ID: mdl-30592587

17.

Hairy cell: young living longer but not cured.

Grever, Michael R.

Blood ; 123(2): 150-1, 2014 Jan 09.

Artículo en Inglés | MEDLINE | ID: mdl-24408202

18.

Validation of ZAP-70 methylation and its relative significance in predicting outcome in chronic lymphocytic leukemia.

Claus, Rainer; Lucas, David M; Ruppert, Amy S; Williams, Katie E; Weng, Daniel; Patterson, Kara; Zucknick, Manuela; Oakes, Christopher C; Rassenti, Laura Z; Greaves, Andrew W; Geyer, Susan; Wierda, William G; Brown, Jennifer R; Gribben, John G; Barrientos, Jacqueline C; Rai, Kanti R; Kay, Neil E; Kipps, Thomas J; Shields, Peter; Zhao, Weiqiang; Grever, Michael R; Plass, Christoph; Byrd, John C.

Blood ; 124(1): 42-8, 2014 Jul 03.

Artículo en Inglés | MEDLINE | ID: mdl-24868078

19.

A phase 1 clinical trial of flavopiridol consolidation in chronic lymphocytic leukemia patients following chemoimmunotherapy.

Awan, Farrukh T; Jones, Jeffrey A; Maddocks, Kami; Poi, Ming; Grever, Michael R; Johnson, Amy; Byrd, John C; Andritsos, Leslie A.

Ann Hematol ; 95(7): 1137-43, 2016 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-27118540

20.

Clara D. Bloomfield, M.D. (1942-2020): Legacy in Leukemia Research.

Grever, Michael R.

Oncologist ; 25(6): 543-544, 2020 06.

Artículo en Inglés | MEDLINE | ID: mdl-32463139

Portal de Búsqueda de la BVS Enfermería

Información y Conocimiento para la Salud

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar:

Long-term outcomes in patients with relapsed or refractory hairy cell leukemia treated with vemurafenib monotherapy.

The impact of increasing karyotypic complexity and evolution on survival in patients with CLL treated with ibrutinib.

Phase 2 study of ibrutinib in classic and variant hairy cell leukemia.

Patient characteristics that predict Richter's transformation in patients with chronic lymphocytic leukemia treated with ibrutinib.

Prognostic significance of translocations in the presence of mutated IGHV and of cytogenetic complexity at diagnosis of chronic lymphocytic leukemia.

Phase I Study of Veliparib on an Intermittent and Continuous Schedule in Combination with Carboplatin in Metastatic Breast Cancer: A Safety and [18F]-Fluorothymidine Positron Emission Tomography Biomarker Study.

Two-inhibitor salvage therapy for hairy cell leukemia.

A phase I study of lenalidomide plus chemotherapy with idarubicin and cytarabine in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome.

Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia.

Population pharmacokinetics of lenalidomide in patients with B-cell malignancies.

Targeting Mutant BRAF in Relapsed or Refractory Hairy-Cell Leukemia.

A novel regimen for relapsed/refractory adult acute myeloid leukemia using a KMT2A partial tandem duplication targeted therapy: results of phase 1 study NCI 8485.

Biomedical Science Undergraduate Major: A New Pathway to Advance Research and the Health Professions.

Safety and activity of BTK inhibitor ibrutinib combined with ofatumumab in chronic lymphocytic leukemia: a phase 1b/2 study.

The revised guidelines for the diagnosis and management of hairy cell leukaemia and the hairy cell leukaemia variant.

Case 28-2018: A Man with Epistaxis, Pain and Erythema of the Forearm, and Pancytopenia.

Hairy cell: young living longer but not cured.

Validation of ZAP-70 methylation and its relative significance in predicting outcome in chronic lymphocytic leukemia.

A phase 1 clinical trial of flavopiridol consolidation in chronic lymphocytic leukemia patients following chemoimmunotherapy.

Clara D. Bloomfield, M.D. (1942-2020): Legacy in Leukemia Research.